Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised CRISPR Therapeutics on the deal. CRISPR Therapeutics (NASDAQ: CRSP) announced its collaboration agreement with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to develop, manufacture, and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised CRISPR Therapeutics on the deal. CRISPR Therapeutics (NASDAQ: CRSP) announced its collaboration agreement with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to develop, manufacture, and...
You must be a Standard 1 Year member to access this content.
Rajaram Legal advised Matrix Partners India, while Goodwin Procter advised Razorpay. Razorpay raised approx. INR 1208 crores ($160 million) in its Series E funding round led...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Cado Security Ltd on the deal. Cado Security Ltd announced its $10 million Series A funding round. Cado Security provides the first and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vascular Biogenics Ltd. on the deal. Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT) announced the closing of its underwritten public offering...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Roman DBDR, while Morgan, Lewis & Bockius LLP advised CompoSecure on the deal. Simpson Thacher served as counsel to the placement agents....
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP and Loyens & Loeff advised Lauxera Capital Partners on the deal, while NautaDutilh assisted LUMICKS Technologies B.V. Lauxera Capital Partners announced their investment...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Lauxera Capital Partners on the deal. Lauxera Capital Partners announced their investment in LUMICKS as part of a $93 million Series D Financing....
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Charlesbank Capital Partners on the deal, while Simpson Thacher advised KKR. Charlesbank Capital Partners and its portfolio company Ensono signed a definitive agreement...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Tango Therapeutics on the deal while Wilson Sonsini Goodrich & Rosati represented BCTG Acquisition Corp. Tango Therapeutics announced its definitive merger agreement with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Cerevel Therapeutics on the deal. Ropes & Gray represented Bain Capital, while Wyrick Robbins Yates & Ponton LLP acted as legal counsel...
You must be a Standard 1 Year member to access this content.
